MS4A1, CD19, TCL1A, CCL19, CXCL9, CD3G, and CD3D might be potential diagnostic biomarkers associated with the progression of pSS, which remains to be verified based on a larger sample. This evidence concerns the gene CCL19 and peeling skin syndrome.